Aberlyn Capital Management, a venture leasing company specializing in providing capital to biotechnology firms, proposed to introduce a new product. Aberlyn rent will be based on an intangible product: patent biotech firm. This creates a number of short and long term problems. "Hide
by Josh Lerner, Peter Tufano Source: Harvard Business School 27 pages. Publication Date: January 12, 1994. Prod. #: 294083-PDF-ENG
Related Case Solutions & Analyses:
Olympia Machine Company Inc.
Beginning with Children Foundation
Intevis: Brokering the Boundaryless Career
Long-Term Capital Management L.P. (C)
Emergent strategy
Pactera’s Expansion in the United States
Joseph Vigneault and the Capital Pool Company Program
OpenPlug (B): Their Way Out of the Dark
SACD
Myriad (A): Breast Cancer Testing in Britain
